Reinhard Voll
4Patents
0h-index
10Co-inventors
35Inventor score
Filing activity: Aug 11, 2003 → Jul 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7262167B2 | Drug, in particular for modulating the immunological response for the control of viruses, tumors, bacteria and parasites | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11466289B2 | NF-KB signaling pathway-manipulated dendritic cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US9862968B2 | NF-κB signaling pathway-manipulated dendritic cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US12152247B2 | NF-KB signaling pathway-manipulated dendritic cells | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.